Evaluation of the Argos System to Estimate Cardiac Output
ConditionShock
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorBicetre Hospital
About this trial
The goal of this observational study is to evaluate the reliability of the Argos system to track changes in cardiac output in critically ill patients. The main question it aims to answer is:
Does cardiac output changes induced by fluid administration or changes in norepinephrine dosage can be tracked by the Argos system, compared to transpulmonary thermodilution device.
Eligibility criteria
Qualifiers
Age ≥18 years old
Hospitalisation in intensive care
Haemodynamic monitoring with transpulmonary thermodilution already in place
Hemodynamic intervention deemed necessary by the clinician in charge of the patient
Disqualifiers
Pregnancy
Other therapeutic modification during volume expansion or the vasopressor test
Refusal to participate by relatives of the patient or the patient himself or herself
Non availability of investigators
Trial design
Treatments tested in this trial
- Fluid bolus
- Norepinephrine
Treatment groups
120 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov